FCGR3A and neoplasm: Here, we explored whether tumor growth inhibition could be enhanced by the combined administration of the NK92 cell line, currently in clinical development [55,56,57], transduced to express CD16 and the bispecific C-7 VHH in co-cultures with single-cell suspensions derived from peritoneal metastatic CRC.